Tuhura Bionsciences Inc Share Price

NASDAQ: HURA

Small Cap

$2.51

+0.12

(+5.02%)

Live

as on September 16, 2025 at 9:35 pm IST

$₹

Tuhura Bionsciences Inc Stock Performance

as on September 16, 2025 at 9:35 pm IST

Day's Low
Day's High
$2.36
Day's Price Range
$2.53
$2.51
5.98%
Downside
0.80%
Upside
52 Week's Low
52 Week's High
$1.8
52-Week Price Range
$7.93
$2.51
28.29%
Downside
215.94%
Upside

Tuhura Bionsciences Inc share price movements today

Previous Close: $2.39
Open: $2.41
Volume: 318.8K
Day's Low - High: $2.36 - $2.53
52 Week Low - High: $1.8 - $7.93

Tuhura Bionsciences Inc Historical Returns

1 Month Return: -21.9 %
3 Month Return: -7 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Tuhura Bionsciences Inc Stock Fundamentals & Key Indicators

Check Tuhura Bionsciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$125.1M

EPS (TTM)

-0.42

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

0.00%

Tuhura Bionsciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tuhura Bionsciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Tuhura Bionsciences Inc	NA	$125.1M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Tuhura Bionsciences Inc Stock's Interest Amongst Investors

Search interest for Tuhura Bionsciences Inc Stock has decreased by -71% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:-71% versus previous 30 day period

Tuhura Bionsciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Income	-18	-4	-3	-2	-6	-9
EBITDA	-18	-4	-	-2	-	-9
Interest Expense	-	0	1	-	-	-
Depreciation	0	0	0	0	0	0
Income Before Tax	-18	-4	-5	-2	-6	-9
Income Tax Expense	-	-	-	-	-	-
Net Income	-18	-4	-5	0	-6	-9
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Tuhura Bionsciences Inc Annual Profit & Loss

All numbers in Millions USD

	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	-	-	-	-
Gross Profit	-	-	-	0
Operating Income	-7	-9	-29	-17
EBITDA	-6	-9	-29	-17
Interest Expense	0	-	0	4
Depreciation	0	0	0	0
Income Before Tax	-7	-9	-29	-21
Income Tax Expense	-	-	0	-
Net Income	-7	-9	-29	-21
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Tuhura Bionsciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	0	-1	-4	-5	-2	-5	-6	-16
Operating Cash Flow	-1	-	-2	-3	-5	-1	-2	-4	-10
Investing Cash Flow	-	-	0	-	-	-	0	-	-1
Financing Cash Flow	0	-	2	4	12	-	-3	0	8
Change in Cash	-	-	-	0	7	-1	-	-6	-4

Tuhura Bionsciences Inc Annual Cash Flow

All numbers in Millions USD

	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Net Income	-8	-11	-8	-9	-38	-7	-9	-29	-21
Operating Cash Flow	-8	-9	-6	-7	-18	-6	-7	-7	-14
Investing Cash Flow	0	0	-	-	0	0	0	-1	-6
Financing Cash Flow	8	9	4	6	26	7	16	2	29
Change in Cash	-	-	-	-	-	0	8	-10	8

Insights on Tuhura Bionsciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 130.0%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 215.6%
NEGATIVE IMPACT
Price Dip
In the last 1 month, HURA stock has moved down by -21.9%

About Tuhura Bionsciences Inc

TuHURA Biosciences, Inc. is a Phase III registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. Its lead innate immune agonist, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It has initiated a single randomized placebo-controlled Phase III registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) compared to Keytruda plus placebo in first-line treatment for advanced or metastatic Merkel Cell Carcinoma. It is leveraging its Delta Opioid Receptor technology to develop bi-specific antibody drug conjugates and antibody peptide conjugates targeting Myeloid Derived Suppressor Cells to inhibit their immune-suppressing effects on the tumor microenvironment to prevent T cell exhaustion and acquired resistance to checkpoint inhibitors and cellular therapies. It is also focused on the novel VISTA inhibiting mAb, known as TBS-2025.

Organisation	Tuhura Bionsciences Inc
Headquarters	10500 University Center Drive, Tampa, FL, United States, 33612
CEO	Dr. James A. Bianco M.D.
E-voting on shares	Click here to vote

Key Management of Tuhura Bionsciences Inc

Name	Title
Dr. James A. Bianco M.D.	President, CEO & Director
Mr. Dan Dearborn CPA	Executive VP of Finance & CFO
Mr. Michael Lawman	Co-Founder
Ms. Patricia Lawman	Co-Founder
Mr. Michael Krsulich	Head of Quality Assurance
Dr. Bertrand Le Bourdonnec Ph.D.	Executive VP, Head of Drug Discovery, Early Development, & Program Management

FAQs

What is Tuhura Bionsciences Inc share price today?

Tuhura Bionsciences Inc share price today is $2.51 as on September 16, 2025 at 9:35 pm IST. Tuhura Bionsciences Inc share today touched a day high of $2.53 and a low of $2.36.

What is the 52 week high and 52 week low for Tuhura Bionsciences Inc share?

Tuhura Bionsciences Inc share touched a 52 week high of $7.93 on October 18, 2024 and a 52 week low of $1.8 on March 10, 2025. Tuhura Bionsciences Inc stock price today i.e. September 16, 2025 at 9:35 pm IST is trending at $2.51,which is 68.35% down from its 52 week high and 39.44% up from its 52 week low.

What is Tuhura Bionsciences Inc's market capitalisation today?

Tuhura Bionsciences Inc market capitalisation is $0.00T as on September 16, 2025 at 9:35 pm IST.

How to invest in Tuhura Bionsciences Inc Stock (HURA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tuhura Bionsciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tuhura Bionsciences Inc Shares that will get you 0.5976 shares as per Tuhura Bionsciences Inc share price of $2.51 per share as on September 16, 2025 at 9:35 pm IST.

What is the minimum amount required to buy Tuhura Bionsciences Inc Stock (HURA) from India?

Indian investors can start investing in Tuhura Bionsciences Inc (HURA) shares with as little as ₹88.042 or $1 (as of September 16, 2025 at 9:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Tuhura Bionsciences Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 9:40 pm IST). Based on Tuhura Bionsciences Inc share’s latest price of $2.51 as on September 16, 2025 at 9:35 pm IST, you will get 3.9841 shares of Tuhura Bionsciences Inc. Learn more about fractional shares .